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Introduction
Cyclodextrins (CDs) are cyclic oligosaccharides with sig-
nificant application in the pharmaceutical, food and cos-
metic industries [1, 2]. Naturally occurring CDs are com-
posed of six, seven or eight d-glucopyranoside units in a 
toroidal structure, possessing a hydrophobic interior and 
hydrophilic exterior. Accordingly, CDs have an ability to 
encapsulate and solubilize hydrophobic guest species in 
water through host–guest complexation [3, 4]. The char-
acteristic properties of the substance, such as solubility, 
chemical reactivity, or spectral property, are changed after 
guest compound is encapsulated. Due to these major fea-
tures, CDs can be utilized in different areas of medicinal 
chemistry. Recently, these host–guest interactions have 
been adopted to assemble polymer nanoparticles for drug 
and gene delivery. Given their biocompatibility, CDs have 
been used as host units for the synthesis of host–guest 
delivery carriers. One example of such carriers is diamide 
linked γ-cyclodextrin (γ-CD) dimers that have been 
described as molecular-scale delivery capsules for the anti-
cancer agent curcumin [5]. In vivo therapeutic efficacy has 
been reported for nanoparticles assembled from camptoth-
ecin conjugated β-CD polymers [6]. Additionally, cationic 
β-CD polymer derived nanoparticles have been found to be 
efficient non-viral delivery vectors for siRNA in humans 
[7]. Also cyclodextrin-based nanosponges can form com-
plexes with many lipophilic and hydrophilic drugs. They 
can be used for protecting easily degradable molecules and 
also could be used to improve the solubility of poorly solu-
ble drugs. For this reason CD-based nanosponges could be 
Abstract Recently a great interest in the field of pro-
tein engineering and the design of innovative drug deliv-
ery systems employing specific ligands such as cyclodex-
trins is observed. The paper reports the solid state, thermal 
method for protein coupling with β-cyclodextrin and the 
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construct innovative bioactive molecules for biological and 
medical applications.
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used as stable delivery systems and innovative drug carries 
for therapeutic purposes [8–10].
CDs based rotaxans and polyrotaxanes have been 
employed as delivery carriers [11, 12]. Furthermore, by 
affecting the intermolecular interactions of proteins CDs 
can interfere with their oligomerization and aggregation 
processes causing a stabilizing effect [13].
Cyclodextrins, due to their possibility to form host–guest 
complexes with many drugs, can be used to modify the 
structure of proteins. Supramolecular and covalent CD-
protein conjugates has been of great interest in the field of 
protein engineering. These conjugates are promising for 
delivery of anticancer drugs [14, 15].
The solid state, thermal reaction between proteins and 
reducing sugar was first described by Lea [16]. Then, this 
approach was further developed by Boratyński and Roy 
[17] as a method for protein glycation and the synthesis of 
biologically active neoglycoconjugates [18]. Also, experi-
ments on albumin, fibrinogen-methotrexate and lysozyme 
glycation show that careful choice of temperature and reac-
tion time ensures the retention of the biological activity 
of the proteins [19, 20]. We have previously reported the 
usefulness of mono-6-O-formyl-β-CD in the modifica-
tion of proteins in thermal reactions in solid state. In that 
paper we presented the possibility of creating CD-protein 
conjugates, and the best conditions for carrying out this 
reaction have been determined. The obtained CD-BPTI 
and CD-lysozyme conjugates were characterized by mass 
spectrometry. MALDI-TOF spectra clearly indicate that in 
both obtained conjugates, one or two molecules of β-CD to 
the protein molecule were attached. We proved that ther-
mal reaction in solid state between lysozyme and mono-6-
O-formyl-β-CD is temperature and solvent dependent. The 
use of higher temperature increases the reaction yield but 
also results in more than one β-CD molecules attached to 
protein [21].
Herein, we report the effect of β-CD conjugation on 
protein physicochemical and biological properties. As a 
model protein, we have chosen lysozyme from egg white, 
molecule with a well-defined structure and biological func-
tions. In our present paper we used DMSO with addition of 
phosphate buffer (1%) as reaction medium (for high reac-
tion yield) and after freeze drying, temperature 100 °C for 
10  min (to obtain predominantly one β-CD molecule per 
lysozyme). The proposed procedure give a new perspec-
tives for the use this method in the synthesis of biologically 
active conjugates. The obtained conjugates could be prom-
ising in drug delivery systems especially for hydrophobic 
drugs with low solubility (Scheme 1).
Experimental
Reagents and solvents
Crystalline β-CD, lysozyme from chicken egg white, imi-
dazole, p-toluenesulfonyl chloride, collidine (2,4,6-trimeth-
ylpyridine), dimethylsulfoxide (DMSO) were obtained 
from Sigma–Aldrich, St. Louis, USA. Inorganic salts and 
other solvents were kindly provided by POCH, Gliwice, 
Poland. Dimethylsulfoxide (DMSO) and collidine were 
distilled under a vacuum and stored under a 4 Å molecular 
sieve. Other solvents were used without initial purification. 
High purity water was generated with a Direct-Q® appara-
tus (Millipore, Billerica, USA). Quartz cells were used for 
UV and circular dichroism measurements (Hellma Analyt-
ics, Mullheim, Germany).
Synthesis of mono-6-O-formyl-β-CD
One gram (0.78  mmol) of mono-6-tosyl-β-cyclodextrin, 
recrystallized twice from hot water, was dissolved in 
DMSO (10  mL). Collidine (1  mL, 7.6  mmol) was added 
and the solution was heated at 135 °C for 1.5 h. The result-
ing slightly brown solution was added to acetone (100 mL) 
and the white precipitate was collected on a Büchner 
funnel in a vacuum. The solid was resuspended in ace-
tone (100  mL) and collected in a vacuum. This step was 
repeated twice. Finally, the white product was dried under 
a vacuum for 24 h. 1H NMR (600 MHz, DMSO-d6) δ 9.69 
(s, 1 H, CHO), 5.80–5.63 (m, 14 H, OH-2, OH-3), 4.93 (t, 
J = 4.9 Hz 1 H, H1), 4.82 (d, J = 4.8 Hz, 1 H, H1), 4.44 (t, 
Scheme 1  Synthesis of β-CD/lysozyme conjugate
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J = 4.4 Hz, 6 H, OH-6), 4.19 (d, J = 4.18 Hz, 1 H, CHCHO), 
3.74– 3.50 (m, 27 H, H1,H3, H6a,b), 3.40–3.25 (m, 14 H, 
H-2, H-4); 13C NMR (150 MHz, DMSO-d6) δ 198.8, 102.4, 
73.5, 72.9, 72.5, 60.4, 56.5; ESI-MS calcd for  C42H68O35 
1132.968, found 1133.357.
Synthesis of L-CD conjugates via thermal treatment 
in the solid state
Lysozyme from chicken egg white (10 mg, 0.7 µmol) and 
mono-6-O-formyl-β-CD (10 mg, 8.8 µmol) were dissolved 
in dry DMSO (2 mL). The lysozyme and conjugate concen-
tration were determined by measurement of the absorbance 
at λ = 280  nm, using ε = 37 750  cm−1  M−1 [22]. Finally, 
phosphate buffer (100  mM, pH = 7.2) was added to the 
reaction mixture to a final concentration of 1% (v/v). Sub-
sequently, the whole mixture was stirred, frozen in liquid 
nitrogen and freeze-dried (Christ, Alpha 2–4 LSC, Oster-
ode am Harz, Germany) at 0.1 mBar and room temperature. 
After freeze drying, the reaction mixtures, in powdered 
form, were placed in hermetically capped glass tubes under 
an argon atmosphere. The samples were heated for 10 min 
in an oven with forced air circulation (Elkon KC-100/200, 
Lodz, Poland), equilibrated at 100 ± 0.5 °C, then cooled to 
room temperature and dissolved in acetate buffer (0.4 mL, 
100 mM, containing 400 mM sodium chloride, pH 4.0).
Purification of the L-CD conjugate
Purification was performed using the Ultimate 3000 HPLC 
system (Dionex, Sunnyvale, USA) and an HIC column 
(BioSiute Phenyl, 10  µm, 7.5 × 75  mm). Runs were per-
formed at room temperature using a 1.0 mL/min isocratic 
flow rate of acetate buffer (100  mM, containing 400  mM 
sodium chloride, pH 4.0). The fraction containing the L-CD 
conjugate was concentrated by ultrafiltration (Nanosep™ 
Omega; Pall corp., Port Washington, USA) using 3  kDa 
cut-off membranes and was then transferred into phosphate 
buffer (64 mM, containing 10% w/w of glycerol, pH 7.2).
NMR measurement
NMR spectra were recorded at 600  MHz frequency with 
an Avance II Bruker Ultrashield Plus spectrometer and a 
5 mm sample tube in DMSO-d6 solution without internal 
standard. All spectra were obtained at ambient temperature. 
1H NMR and 13C NMR spectra were recorded at 600 and 
150 MHz, respectively.
Liquid chromatography-mass spectrometry (LC-MS)
LC-MS analyses were carried out on a MicrOTOF-
Q II hybrid quadrupole time-of-flight (Q-TOF) mass 
spectrometer (Bruker Daltonics, Bremen, Germany) 
equipped with an electrospray ionization (ESI) source and 
coupled with an Ultimate 3000 RS HPLC system (Dionex, 
Sunnyvale, USA). Samples desalting ware performed using 
a BioBasic column (C8, 300 Å, 5 µm, 2.1 × 50 mm; Thermo 
Scientific, Waltham, USA) at room temperature using con-
ditions as follows: linear gradient of solution A (0.1% aque-
ous formic acid (FA)) and B  (CH3CN with 0.1% FA) from 
5 to 70% of solution B in 20  min, flow rate 0.2  mL/min, 
injection volume 5µL, and detection via MS. All ESI-MS 
experiments were performed in positive ion mode and cali-
brated with the sodium formate (10 mM) in water/isopro-
panol mixture (50/50 v/v) in quadratic + HPC regression 
mode. Data were acquired with microTOF control 3.0 and 
processed for calibration and the charge deconvolution of 
spectra with DataAnalysis 4.0 software (Bruker Daltonics, 
Bremen, Germany). Standard deviations were estimated by 
repeated calculations of the average molecular mass of the 
protein for all ions (m/z) observed in the protein envelope.
Ultraviolet spectroscopy (UV) measurements
All the spectrophotometric measurements were conducted 
on a  Specord® 250 (AnalyticJena, Jena, Germany) spec-
trophotometer equipped with 1.0  cm quartz cells (Hellma 
Analytics, Mullheim, Germany) at ambient temperature. 
The absorption spectra have been resolved in the sum of 
their Gaussian constituents. The process of the decompo-
sition of the absorption spectra of the crystal violet in the 
sum of the corresponding Gaussians was carried out using 
Fityk software [23].
Dynamic light scattering (DLS) measurement
Hydrodynamic parameters of the lysozyme and L-CD con-
jugates were characterized using the DLS technique. This 
technique allows for the measurement of time-dependent 
fluctuations in the intensity of scattered light due to molec-
ular Brownian motion in solution. The analysis of the inten-
sity fluctuations allows the determination of the diffusion 
coefficients of particles, which are converted into a size 
distribution (Stokes–Einstein equation). The sample solu-
tion was illuminated by a 633 nm laser, and the light inten-
sity scattered at an angle of 173° was measured. At least 
six consecutive measurements were carried out for each 
sample. All samples (concentration ca 0.2 mM) were meas-
ured at 25 °C (Peltier temperature controller cell holder) in 
phosphate buffer (64 mM, containing 10% w/w of glycerol, 
pH 7.2) using a Zetasizer Nano ZS (Malvern Instruments, 
Worcestershire, U.K.) in a 12-µL quartz cuvette. DLS data 
were analyzed using DTS 6.10 software (Malvern Instru-
ments, Worcestershire, U.K.). The intensity particle size 
distributions were obtained using the General Purpose 
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algorithm included in the DTS software. The following 
parameters were used: protein refractive index (1.450), and 
solvent viscosity (1.212 × 10− 4 Pa × s).
The effect of temperature on the hydrodynamic param-
eters (determination of melting points -  TM) of L-CD con-
jugates was estimated via DLS at 1 °C intervals from 25 to 
80 °C and a 3 min equilibrium time at each measurement 
temperature. The melting point was defined as the tempera-
ture at which the hydrodynamic diameter started to increase 
exponentially with temperature.
Circular dichroism (CD) measurement
Circular dichroism spectra were recorded at 25 °C on a 
Jasco 815 spectropolarimeter equipped with a Peltier tem-
perature controller cell holder. Three spectra (recorded with 
a data pitch of 0.1 nm, a band width of 1 nm, with a detec-
tor response time of 4  s at 50 nm/min) were averaged for 
each sample. Quartz cells with a 1  mm light path length 
were used for the measurements. Samples were prepared 
in phosphate buffer (64 mM, containig 10% w/w of glyc-
erol, pH 7.2). Lysozyme and L-CD conjugates concentra-
tions were in the range 6–8 μM for far UV measurements 
and 60–80 μM for near UV measurements. The mean resi-
due ellipticity ({θ}MRW) was calculated using the formula: 
{θ}MRW = (θobsdMRW)/(10lc) where θobsd is the observed 
ellipticity in degrees, MRW is the mean residue molecular 
weight (111.8 for lysozyme), l is the path length in cen-
timeters, and c is the protein concentration in grams per 
milliliter.
Biological activity assay
Enzymatic activity of lysozyme and L-CD conju-
gates was determined using Micrococcus lysodeikticus 
(Sigma–Aldrich, St. Louis, USA) according to the standard 
procedure [24]. Lytic activity was measured at λ = 450 nm 
for 5  min (25 °C) in a total volume 2.6  mL of phosphate 




Mono 6-O-formyl-β-CD was obtained by a simple two-
step procedure. In the first step a mono 6-O-tosyl-β-CD 
was synthesized by reaction of β-cyclodextrin with 
1-(p-toluenesulfonyl) imidazole [25]. In the second step, 
mono 6-O-tosyl-β-CD was oxidized with DMSO as a 
weak base, afford the monoaldehyde [26]. The obtained 
mono-6-O-formyl-β-CD was characterized by 1H and 
13C NMR (Supplementary material Figures  S4 and S5). 
1H NMR spectra show relevant peaks at 9.7 ppm (CHO), 
4.2  ppm (CHCHO) and typical peaks corresponding to 
β-CD. Within the carbon NMR spectra we were also able 
to observe an aldehyde peak at 198 ppm. These date were 
in good agreement with NMR data published previously 
[21, 27].
Thermal treatment in solid state
The L-CD conjugates were successfully obtained using 
thermal reactions in solid state. The physicochemi-
cal properties of the obtained conjugates were studied 
using mass spectrometry (MS), DLS and circular dichro-
ism techniques. It is of interest that no reaction occurs 
between lysozyme and mono-6-O-formyl-β-CD in solu-
tion, i.e. in water/DMSO mixture without reducing agent 
(e.g.  NaCNBH4), but after freeze drying of the reaction 
mixture, in solid state and under elevated temperature, 
it proceeds yielding L-CD conjugates. The solubil-
ity of the obtained conjugates in water was comparable 
with unmodified lysozyme. Thermal treated lysozyme 
(lysozyme (t): dissolved in water/DMSO mixture, freeze 
dried, and heated at 100 °C for 10 min) without an addi-
tion of the mono-6-O-formyl-β-CD shows no essential 
differences in physicochemical parameters and biological 
activity as compared to the untreated, control lysozyme 
(lysozyme(c)).
LC–ESI–MS analysis
Mass spectrometry is a useful tool to study covalent 
modification of proteins [28, 29]. Moreover, it has pre-
viously been found that the net charge of a protein mol-
ecule is sensitive to the protein conformation [30]. Based 
on the MS data it can be concluded that reaction condi-
tions (elevated temperature in solid state) do not cause 
any covalent modification or significant change in spatial 
structure of the lysozyme. Deconvolution of m/z mass 
spectra estimated the average molecular mass differences 
Table 1  Molecular mass differences between lysozyme(c), 
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between lysozymes and L-CD conjugates to be 1114.34 
and 2228.69 Da, which is equivalent to the mass of a one 
or two covalently bound β-CD moieties (Table 1).
Dynamic light scattering analysis
The hydrodynamic parameters obtained from DLS meas-
urement are useful for predicting the stability of proteins 
and their functions [31]. The hydrodynamic diameter and 
polydispersity of L-CD conjugates are slightly higher 
than those for unmodified protein (Fig.  1). The changes 
in hydrodynamic size with temperature are depicted in 
Fig.  2. The L-CD conjugates exhibit lower thermal sta-
bility than lysozyme (c). The melting temperature  (TM) 
of lysozyme (c), lysozyme (t) and L-CD conjugates were 
determined by dynamic light scattering as 70, 70, and 
61 °C, respectively.
Fig. 1  Characterization of 
lysozyme and L-CD conjugates 
using the dynamic light scatter-
ing technique. Size distributions 
are shown according to inten-
sity.  dH—hydrodynamic diam-
eter (nm). Samples (c = 0.2 mM) 
were prepared in phosphate 
buffer (64 mM, containing 10% 
w/w glycerol, pH 7.2)
Fig. 2  Relative hydrodynamic 
diameter dH/dH0 where dH0 is 
the hydrodynamic diameter of 
lysozyme and L-CD conjugates 
at 20 °C determined by the DLS 
method as a function of tem-
perature. Samples (c = 0.2 mM) 
were prepared in phosphate 
buffer (64 mM, containing 10% 
w/w glycerol, pH 7.2)
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Circular dichroism analysis
The effect of both lysozyme modification with mono-6-O-
formyl-β-CD and conjugates synthesis conditions (100 °C 
for 10 min) on the conformational properties of lysozyme, 
as shown by a comparison of circular dichroism spectra 
(Fig. 3), seems to be negligible. Based on the near UV cir-
cular dichroism data (inset to Fig.  3) it can be concluded 
that no essential conformational changes were observed for 
L-CD conjugates, indicating that the cyclodextrin ring did 
not significantly alter the tertiary structure of lysozyme. 
In addition circular dichroism measurements proved that 
thermal reaction conditions do not affect the spatial struc-
ture of lysozyme.
Biological activity of lysozyme and L-CD conjugates
Enzymatic activity analysis of L-CD conjugates shows 
a decreased ability to hydrolyze bacterial cell walls: 
56.2 ± 3.8% as compared to lysozyme(c) (Fig.  4). 
Lysozyme(t) shows no essential differences in biological 
activity (97.2 ± 3.0%) as compared to lysozyme(c). These 
data suggest that reaction conditions (dissolving in water/
DMSO mixture, freeze drying, and heating at 100 °C 
Fig. 3  Far and near (inset) UV 
circular dichroism spectra of 
lysozyme and L-CD conjugates. 
Samples were prepared in phos-
phate buffer (64 mM, containing 
10% w/w of glycerol, pH 7.2). 
Lysozyme and L-CD conjugates 
concentrations were in the range 
6–8 μM and 60–80 μM for 
measurements in far and near 
ultraviolet, respectively
Fig. 4  Biological activity of 
control lysozyme (lysozyme 
(c)), thermal treated lysozyme 
(lysozyme (t)) and L-CD 
conjugates. Enzymatic activity 
was determined using. Micro-
coccus lysodeikticus (Sigma–
Aldrich, ATCC No. 5698, LOT 
No.:111M8601V) according to 
the standard procedure [24]
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for 10  min) do not affect the biological properties of the 
lysozyme (measurement variation 3.0%).
The ability to form inclusion complexes between the 
L-CD conjugates and a model compound (crystal violet) 
ware investigated via UV–Vis spectrophotometry. Crystal 
violet (CV), a tris(p-(dimethylamino)phenyl)-methyl ion, is 
one of the triphenylmethane dyes for which there are many 
studies concerning molecular structures and complexation 
processes by β-CD [32]. The visible absorption spectrum of 
CV in solution appears to be composed of two bands, and 
their origin was interpreted based on the existence of two 
isomers or two ground states [33]. CV can form an inclu-
sion complex through the introduction of an aromatic ring 
in the cavity of the cyclodextrin (absorption signal around 
λ1 = 559  nm and λ2 = 596  nm). In this study, we applied 
visible absorption spectroscopy to investigate the com-
plexes formed by the crystal violet and the β-CD, lysozyme 
and L-CD conjugates. The absorption spectra have been 
resolved as the sum of their Gaussian constituents. The 
process of the decomposition of the absorption spectra of 
the crystal violet in the sum of the corresponding Gauss-
ians was carried out using Fityk software [23]. The addi-
tion of β-CD or L-CD conjugates causes a change in the 
spectral behavior of CV suggesting that L-CD conjugates 
can form inclusion complexes with CV. The efficiency of 
this process is not the same as that of the free cyclodextrin. 
The reason may be the steric hindrance resulting from the 
close location of the β-CD ring with a specific region of the 
protein and hinders CV complexation (Table 2).
In the present study, we demonstrated that lysozyme-
cyclodextrin conjugates can be obtained using an innova-
tive method based on thermal treatment in the solid state, 
without significant secondary or tertiary structure changes 
of the protein. The obtained conjugates were biologically 
active (enzymatic activity of lysozyme) and tethered β-CD 
preserved the ability to form inclusion complexes with the 
model compound. Additionally, it was reported that mono-
6-O-formyl-β-CD is a suitable substrate for such reactions. 
The presented approach also proved a comparable effect on 
the enzymatic activity of the lysozyme with other methods 
used for the preparation of lysozyme conjugates with dif-
ferent compounds [34]. Tethering of the β-CD moieties to 
the lysozyme does not significantly alter its secondary or 
tertiary structures as indicated by circular dichroism meas-
urements, but does affect its hydrodynamic parameters and 
thermal stability. Additionally, this paper demonstrates that 
such conjugates have the possibility to transport various 
therapeutic substances in the form of inclusion complexes. 
These factors show the potential of protein-cyclodextrin 
conjugates for use in biological and medical applications.
Conclusion
This paper presents the usefulness of solid state, thermal 
method for the synthesis of biologically active protein-
β-CD conjugates. The obtained conjugate system fits in 
ongoing research concerning development of new drug 
delivery systems. The systems can extend a new potential-
ity of chemotherapy, administration of antybiotics or treat-
ment of rheumatological diseases.
Acknowledgements This work was partially supported by the 
HIIET PAS (Statutory Fund). We would like to thank Dr. Daniel Kro-
warsch (Department of Protein Biotechnology, Faculty of Biotech-
nology, University of Wroclaw, Poland) for the circular dichroism 
measurements.
Open Access This article is distributed under the terms of the 
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted 
use, distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and indicate if changes were 
made.
References
 1. Szejtli, J.: Introduction and general overview of cyclodextrin 
chemistry. Chem. Rev. (Washington, D.C.) 98(5), 1743–1753 
(1998). doi:10.1021/CR970022C
 2. Dodziuk, H., (ed.): Cyclodextrins and their complexes. vol. Cop-
yright (C) 2016 American Chemical Society (ACS). All Rights 
Reserved. Wiley-VCH Verlag GmbH & Co. KGaA, (2008)
 3. Thompson, D.O.: Cyclodextrins-enabling excipients: their pre-
sent and future use in pharmaceuticals. Crit. Rev. Ther. Drug 
Carrier Syst. 14(1), 1–104 (1997)
 4. Hirayama, F., Uekama, K.: Cyclodextrin-based controlled drug 
release system. Adv. Drug Deliv. Rev. 36(1), 125–141 (1999). 
doi:10.1016/S0169-409X(98)00058-1
 5. Harada, T., Giorgio, L., Harris, T.J., Pham, D.-T., Ngo, H.T., 
Need, E.F., Coventry, B.J., Lincoln, S.F., Easton, C.J., Buchanan, 
G., Kee, T.W.: Diamide Linked γ-Cyclodextrin dimers as molec-
ular-scale delivery systems for the medicinal pigment curcumin 
to prostate cancer cells. Mol. Pharm. 10(12), 4481–4490 (2013). 
doi:10.1021/mp400309s
Table 2  Changes in the spectral behavior of CV (λ1 = 559  nm and 
λ2 = 596  nm) under the addition of lysozyme, β-cyclodextrin and 
L-CD conjugates
The absorption spectra have been resolved in the sum of their Gauss-
ian constituents. Samples were prepared in phosphate buffer (64 mM, 
containing 10% w/w glycerol, pH 7.2)
Mixture, concentration (µM) λ1 (nm) λ1 (nm)
CV (10 µM) 596.5 559.5
CV (10 µM) + Lysozyme (140 µM) 596.7 559.9
CV (10 µM) + β-CD (140 µM) 598.9 561.4
CV (10 µM) + L-β-CD conjugate (140 µM) 597.2 560.8
348 J Incl Phenom Macrocycl Chem (2017) 87:341–348
1 3
 6. Davis, M.E.: Design and development of IT-101, a cyclodextrin-
containing polymer conjugate of camptothecin. Adv. Drug Deliv. 
Rev. 61(13), 1189–1192 (2009). doi:10.1016/j.addr.2009.05.005
 7. Davis, M.E.: The first targeted delivery of siRNA in humans 
via a self-assembling, cyclodextrin polymer-based nanoparti-
cle: from concept to clinic. Mol. Pharm. 6(3), 659–668 (2009). 
doi:10.1021/mp900015y
 8. Trotta, F., Zanetti, M., Cavalli, R.: Cyclodextrin-based nano-
sponges as drug carriers. Beilstein J. Org. Chem. 8, 2091–2099, 
(2012). No. 2235 doi:10.3762/bjoc.8.235
 9. Trotta, F., Dianzani, C., Caldera, F., Mognetti, B., Cavalli, R.: 
The application of nanosponges to cancer drug delivery. Expert 
Opin. Drug Deliv. 11(6), 931–941 (2014). doi:10.1517/1742524
7.2014.911729
 10. Osmani, R.A.M., Bhosale, R.R., Hani, U., Vaghela, R., Kulkarni, 
P.K.: Cyclodextrin based nanosponges: impending carters in 
drug delivery and nanotherapeutics. Curr. Drug Ther. 10(1), 
3–19 (2015). doi:10.2174/157488551001150825095513
 11. Girek, T.: Cyclodextrin-based rotaxanes. J. Incl. Phenom. 
Macrocycl. Chem. 74(1–4), 1–21 (2012). doi:10.1007/
s10847-012-0112-1
 12. Girek, T.: Cyclodextrin-based polyrotaxanes. J. Incl. Phenom. 
Macrocycl. Chem. 76(3–4), 237–252 (2013). doi:10.1007/
s10847-012-0253-2
 13. Serno, T., Geidobler, R., Winter, G.: Protein stabilization by 
cyclodextrins in the liquid and dried state. Adv. Drug Deliv. Rev. 
63(13), 1086–1106 (2011). doi:10.1016/j.addr.2011.08.003
 14. Martinez, A., Mellet, C.O., Garcia Fernandez, J.M.: Cyclodex-
trin-based multivalent glycodisplays: covalent and supramolecu-
lar conjugates to assess carbohydrate-protein interactions. Chem. 
Soc. Rev. 42(11), 4746–4773 (2013). doi:10.1039/c2cs35424a
 15. Fernandez, M., Fragoso, A., Cao, R., Villalonga, R.: Stabiliza-
tion of α-chymotrypsin by chemical modification with monoam-
ine cyclodextrin. Process Biochem. (Oxford, UK) 40(6), 2091–
2094 (2005). doi:10.1016/j.procbio.2004.07.023
 16. Lea, C.H., Hannan, R.S.: Reaction between proteins and reduc-
ing sugars in the dry state. I. Effect of activity of water, of pH, 
and of temperature on the primary reaction between casein 
and glucose. Biochim. Biophys. Acta 3, 313–325 (1949). 
doi:10.1016/0006-3002(49)90100-6
 17. Boratynski, J., Roy, R.: High temperature conjugation of proteins 
with carbohydrates. Glycoconjugate J. 15(2), 131–138 (1998)
 18. Boratynski, J.: Dry reaction of proteins with carbohydrates at 
120 °C yields neoglycoconjugates. Biotechnol. Tech. 12(9), 707–
710 (1998)
 19. Kanska, U., Boratynski, J.: Thermal glycation of proteins by 
d-glucose and d-fructose. Arch. Immunol. Ther. Exp. 50(1), 
61–66 (2002)
 20. Kanska, U., Budzynska, R., Nevozhay, D., Boratynski, J.: Prepa-
ration of mannan-protein conjugates using high-temperature 
glycation. Biotechnol. Appl. Biochem. 49(1), 57–64 (2008). 
doi:10.1042/BA20070024
 21. Girek, T., Goszczynski, T., Girek, B., Ciesielski, W., Boratynski, 
J., Rychter, P.: β-Cyclodextrin/protein conjugates as a innovative 
drug systems: synthesis and MS investigation. J. Incl. Phenom. 
Macrocycl. Chem. 75(3–4), 293–296 (2013). doi:10.1007/
s10847-012-0132-x
 22. Aune, K.C., Tanford, C.: Thermodynamics of the denaturation 
of lysozyme by guanidine hydrochloride. I. Dependence on pH 
at 25.deg. BioChemistry. 8(11), 4579–4585 (1969). doi:10.1021/
bi00839a052
 23. Wojdyr, M.: Fityk: a general-purpose peak fitting program. J. 
Appl. Crystallogr. 43(5, Pt. 1), 1126–1128 (2010). doi:10.1107/
S0021889810030499
 24. Shugar, D.: Measurement of lysozyme activity and the ultraviolet 
inactivation of lysozyme. Biochim. Biophys. Acta. 8, 302–309 
(1952). doi:10.1016/0006-3002(52)90045-0
 25. Byun, H.-S., Zhong, N., Bittman, R.: 6 A-O-p-toluenesulfonyl-
β-cyclodextrin. Org. Synth. 77, 225–230 (2000). doi:10.15227/
orgsyn.077.0225
 26. Martin, K.A., Czarnik, A.W.: Facile preparation of the 
β-cyclodextrinyl aldehyde. Tetrahedron Lett. 35(37), 6781–6782 
(1994). doi:10.1016/0040-4039(94)85003-8
 27. Hauch Fenger, T., Bjerre, J., Bols, M.: Cyclodextrin aldehydes 
are oxidase mimics. ChemBioChem 10(15), 2494–2503 (2009). 
doi:10.1002/cbic.200900448
 28. Navea, S., Tauler, R., De Juan, A: Monitoring and modeling of 
protein processes using mass spectrometry, circular dichroism, 
and multivariate curve resolution methods. Anal. Chem. 78(14), 
4768–4778 (2006). doi:10.1021/ac052257r
 29. Mohimen, A., Dobo, A., Hoerner, J.K., Kaltashov, I.A.: A che-
mometric approach to detection and characterization of multi-
ple protein conformers in solution using electrospray ionization 
mass spectrometry. Anal. Chem. 75(16), 4139–4147 (2003). 
doi:10.1021/ac034095+
 30. Dobo, A., Kaltashov, I.A.: Detection of multiple protein con-
formational ensembles in solution via deconvolution of charge-
state distributions in ESI MS. Anal. Chem. 73(20), 4763–4773 
(2001). doi:10.1021/ac010713f
 31. Shiba, K., Niidome, T., Katoh, E., Xiang, H., Han, L., Mori, T., 
Katayama, Y.: Polydispersity as a parameter for indicating the 
thermal stability of proteins by dynamic light scattering. Anal. 
Sci. 26(6), 659–663 (2010). doi:10.2116/analsci.26.659
 32. Garcia-Rio, L., Leis, J.R., Mejuto, J.C., Navarro-Vazquez, A., 
Perez-Juste, J., Rodriguez-Dafonte, P.: Basic hydrolysis of crys-
tal violet in β-cyclodextrin/surfactant mixed systems. Langmuir 
20(3), 606–613 (2004). doi:10.1021/la035477d
 33. Garcia-Rio, L., Godoy, A., Leis, J.R.: Spectroscopic characteri-
zation of crystal violet inclusion complexes in β-cyclodextrin. 
Chem. Phys. Lett. 401(1–3), 302–306 (2005). doi:10.1016/j.
cplett.2004.11.063
 34. Novakovic, I., Andjelkovic, U., Zlatovic, M., Gasic, M.J., Sladic, 
D.: Bioconjugate of lysozyme and the antibacterial marine ses-
quiterpene quinone avarone and its derivatives. Bioconjugate 
Chem. 23(1), 57–65 (2012). doi:10.1021/bc200330m
